<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02879591</url>
  </required_header>
  <id_info>
    <org_study_id>U 9038</org_study_id>
    <nct_id>NCT02879591</nct_id>
  </id_info>
  <brief_title>Enhancing Social Interaction With an AlterEgo Artificial Agent</brief_title>
  <acronym>ALTEREGO</acronym>
  <official_title>Enhancing Social Interaction With an AlterEgo Artificial Agent</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Université Montpellier</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ecole Polytechnique Fédérale de Lausanne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bristol</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>DEUTSCHES FORSCHUNGSZENTRUM FUER KUENSTLICHE</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of AlterEgo is the creation of an interactive cognitive architecture,&#xD;
      implementable in various artificial agents, allowing a continuous interaction with patients&#xD;
      suffering from social disorders, by virtue of changes in behavioural (robot-based) as well as&#xD;
      morphological (avatar-based) properties of that agent. The project includes research in&#xD;
      fundamental and clinical neurosciences, interaction modeling, development of new&#xD;
      computer-vision techniques and human-robot interfaces, as well as evaluation of the scenarios&#xD;
      with patients before, during, and after training sessions. At the end of the project, the&#xD;
      investigators will produce a new avatar-based clinical method able to enhance social&#xD;
      interaction of patients.&#xD;
&#xD;
      The first challenge of this project is to create an avatar alter ego of a patient. Based on&#xD;
      recent work in social robotics and neurosciences, the investigators hypothesize that if&#xD;
      patients face artificial agents morphologically and behaviourally similar to them, they will&#xD;
      increase their social interaction. The second challenge is to transform the morphology and&#xD;
      the behaviour of the similar artificial agent into that of a healthy and different agent. The&#xD;
      investigators assume that the smooth and continuous behavioural shift from similar/unhealthy&#xD;
      to complementary/healthy social behaviour will lead to a better social rehabilitation.&#xD;
      AlterEgo opens the door to a new generation of social artificial agents in service robotics.&#xD;
      AlterEgo is an interdisciplinary project at the interaction of Social Motor Neurosciences&#xD;
      (UM1), Robotics (EPFL), Complex Systems Dynamics (UOB), Computer Vision (DFKI), and&#xD;
      Psychiatry (CHU).&#xD;
&#xD;
      This project includes a set of experiments that started in april 2014 and will terminate in&#xD;
      september 2016 before undergoing a randomised clinical research.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of patient enhancing social intercation</measure>
    <time_frame>3 months</time_frame>
    <description>improvement of social interactions (interpersonal relations, items 1 to 7 on Specific Levels Of Functioning, SLOF)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of patient accepting avatar therapy</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>questionnaire for Faisability of avatar therapy</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">246</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Patients with schizophrenia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with schizophrenia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Healthy volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Social Skills training with Avatar therapist</intervention_name>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with schizophrenia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients suffering from schizophrenia according to the criteria proposed in the&#xD;
             DSM-IV-TR&#xD;
&#xD;
          -  Aged between 18 and 60 years old.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of head trauma&#xD;
&#xD;
          -  History of neurological disorders (epilepsy disease, multiple sclerosis, Parkinson's&#xD;
             disease, amyotrophic lateral sclerosis, Huntington's disease, stroke)&#xD;
&#xD;
          -  An actual ECT treatment&#xD;
&#xD;
          -  Substance Abuse and / or current Substance dependence (excluding tobacco and&#xD;
             cannabis).&#xD;
&#xD;
          -  Pregnant women, new mothers and nursing mothers&#xD;
&#xD;
          -  People private of their liberty&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Delphine Capdevielle, MD, PhD</last_name>
    <phone>0033467339727</phone>
    <email>d-capdevielle@chu-montpellier.Fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stéphane Raffard, PhD</last_name>
    <phone>0033467339702</phone>
    <email>s-raffard@chu-montpellier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service Universitaire de psychiatrie adulte, University Hospital of Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delphine Capdevielle</last_name>
      <phone>0033467339727</phone>
      <email>d-capdevielle@chu-montpellier.fr</email>
    </contact>
    <contact_backup>
      <last_name>Stéphane Raffard, PhD</last_name>
      <phone>0033467339702</phone>
      <email>s-raffard@chu-montpellier.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>July 29, 2016</study_first_submitted>
  <study_first_submitted_qc>August 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2016</study_first_posted>
  <last_update_submitted>August 24, 2016</last_update_submitted>
  <last_update_submitted_qc>August 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

